These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 24895896)
21. Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Rahman T; Rahmatullah M Bioorg Med Chem Lett; 2010 Jan; 20(2):537-40. PubMed ID: 19969454 [TBL] [Abstract][Full Text] [Related]
22. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B. Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles. Ogunrombi MO; Malan SF; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP Bioorg Med Chem; 2008 Mar; 16(5):2463-72. PubMed ID: 18065227 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Hassan SY; Khattab SN; Bekhit AA; Amer A Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides. Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554 [TBL] [Abstract][Full Text] [Related]
28. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Binda C; Newton-Vinson P; Hubálek F; Edmondson DE; Mattevi A Nat Struct Biol; 2002 Jan; 9(1):22-6. PubMed ID: 11753429 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies. Khattab SN; Hassan SY; Bekhit AA; El Massry AM; Langer V; Amer A Eur J Med Chem; 2010 Oct; 45(10):4479-89. PubMed ID: 20708306 [TBL] [Abstract][Full Text] [Related]
30. Orientation of oxazolidinones in the active site of monoamine oxidase. Jones TZ; Fleming P; Eyermann CJ; Gravestock MB; Ramsay RR Biochem Pharmacol; 2005 Aug; 70(3):407-16. PubMed ID: 15950194 [TBL] [Abstract][Full Text] [Related]
31. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors. Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943 [TBL] [Abstract][Full Text] [Related]
32. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases. Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Maccioni E; Cardia MC; Yáñez M; Orallo F; Alcaro S; Ortuso F; Cirilli R; Ferretti R; Distinto S; Kirchmair J; Langer T Bioorg Med Chem; 2010 Jul; 18(14):5063-70. PubMed ID: 20579890 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of monoamine oxidase by phthalide analogues. Strydom B; Bergh JJ; Petzer JP Bioorg Med Chem Lett; 2013 Mar; 23(5):1269-73. PubMed ID: 23374869 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
36. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
37. Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B. Binda C; Wang J; Li M; Hubalek F; Mattevi A; Edmondson DE Biochemistry; 2008 May; 47(20):5616-25. PubMed ID: 18426226 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors. Prins LH; Petzer JP; Malan SF Bioorg Med Chem; 2009 Nov; 17(21):7523-30. PubMed ID: 19804982 [TBL] [Abstract][Full Text] [Related]
39. Molecular docking of inhibitors into monoamine oxidase B. Harkcom WT; Bevan DR Biochem Biophys Res Commun; 2007 Aug; 360(2):401-6. PubMed ID: 17597580 [TBL] [Abstract][Full Text] [Related]
40. Chalcones: a valid scaffold for monoamine oxidases inhibitors. Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]